165 related articles for article (PubMed ID: 27017785)
1. [Treatment and prevention of iphosphamide-induced encephalopathy].
Sunela K; Bärlund M
Duodecim; 2016; 132(4):314-7. PubMed ID: 27017785
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide encephalopathy and use of methylene blue. A case report of different sequential neurotoxicity.
Giovanis P; Garna A; Marcante M; Nardi K; Giusto M
Tumori; 2009; 95(4):545-6. PubMed ID: 19856674
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue reversal of ifosfamide-related encephalopathy.
Raj AB; Bertolone SJ; Jaffe N
J Pediatr Hematol Oncol; 2004 Feb; 26(2):116. PubMed ID: 14767201
[No Abstract] [Full Text] [Related]
4. Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy.
Turner AR; Duong CD; Good DJ
Clin Oncol (R Coll Radiol); 2003 Oct; 15(7):435-9. PubMed ID: 14570094
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant.
Howell JE; Szabatura AH; Hatfield Seung A; Nesbit SA
J Oncol Pharm Pract; 2008 Sep; 14(3):157-62. PubMed ID: 18719071
[TBL] [Abstract][Full Text] [Related]
6. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide neuropsychiatric toxicity in patients with cancer.
Alici-Evcimen Y; Breitbart WS
Psychooncology; 2007 Oct; 16(10):956-60. PubMed ID: 17278152
[TBL] [Abstract][Full Text] [Related]
8. Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy.
Durand JP; Gourmel B; Mir O; Goldwasser F
Ann Oncol; 2007 Apr; 18(4):808-9. PubMed ID: 17389531
[No Abstract] [Full Text] [Related]
9. Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.
Jarkowski A
Am J Health Syst Pharm; 2008 Dec; 65(23):2229-31. PubMed ID: 19020190
[TBL] [Abstract][Full Text] [Related]
10. Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue.
Snyder M; Gangadhara S; Brohl AS; Ludlow S; Nanjappa S
Cancer Control; 2017; 24(5):1073274817729070. PubMed ID: 28975823
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide encephalopathy.
Ajithkumar T; Parkinson C; Shamshad F; Murray P
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):108-14. PubMed ID: 17355105
[TBL] [Abstract][Full Text] [Related]
12. Role of thiamine in managing ifosfamide-induced encephalopathy.
Hamadani M; Awan F
J Oncol Pharm Pract; 2006 Dec; 12(4):237-9. PubMed ID: 17156595
[TBL] [Abstract][Full Text] [Related]
13. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide-induced encephalopathy in patients with uterine sarcoma.
Liu YL; Tsai SH; Chang FW; Yu MH
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):77-80. PubMed ID: 20466298
[TBL] [Abstract][Full Text] [Related]
15. Methylene blue for management of Ifosfamide-induced encephalopathy.
Patel PN
Ann Pharmacother; 2006 Feb; 40(2):299-303. PubMed ID: 16391008
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
Brunello A; Basso U; Rossi E; Stefani M; Ghiotto C; Marino D; Crivellari G; Monfardini S
Drugs Aging; 2007; 24(11):967-73. PubMed ID: 17953463
[TBL] [Abstract][Full Text] [Related]
17. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy.
Küpfer A; Aeschlimann C; Cerny T
Eur J Clin Pharmacol; 1996; 50(4):249-52. PubMed ID: 8803513
[TBL] [Abstract][Full Text] [Related]
18. [Methylene blue in ifosfamide-induced encephalopathy].
Koschuth A; Späth-Schwalbe PE; Possinger K
Dtsch Med Wochenschr; 1996 Sep; 121(39):1210. PubMed ID: 8925751
[No Abstract] [Full Text] [Related]
19. Aprepitant-associated ifosfamide neurotoxicity.
Hansen Ho ; Yuen C
J Oncol Pharm Pract; 2010 Jun; 16(2):137-8. PubMed ID: 19759053
[No Abstract] [Full Text] [Related]
20. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
Sweiss KI; Beri R; Shord SS
Drug Saf; 2008; 31(11):989-96. PubMed ID: 18840018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]